690 related articles for article (PubMed ID: 31926187)
1. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
[TBL] [Abstract][Full Text] [Related]
2. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X
Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan Pathway-Targeted Metabolomics Study on the Mechanism and Intervention of Cisplatin-Induced Acute Kidney Injury in Rats.
Tan B; Chen J; Qin S; Liao C; Zhang Y; Wang D; Li S; Zhang Z; Zhang P; Xu F
Chem Res Toxicol; 2021 Jul; 34(7):1759-1768. PubMed ID: 34110802
[TBL] [Abstract][Full Text] [Related]
4. Hepatic damage exacerbates cisplatin-induced acute kidney injury in Sprague-Dawley rats.
Kim JS; Son JY; Kim KS; Lim HJ; Ahn MY; Kwack SJ; Kim YM; Lee KY; Lee J; Lee BM; Kim HS
J Toxicol Environ Health A; 2018; 81(11):397-407. PubMed ID: 29557720
[TBL] [Abstract][Full Text] [Related]
5. Age-related differences in kidney injury biomarkers induced by cisplatin.
Shin YJ; Kim TH; Won AJ; Jung JY; Kwack SJ; Kacew S; Chung KH; Lee BM; Kim HS
Environ Toxicol Pharmacol; 2014 May; 37(3):1028-39. PubMed ID: 24751685
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics for the identification of early biomarkers of nephrotoxicity in a mouse model of cisplatin-induced acute kidney injury.
Lim YJ; Tonial NC; Hartjes ED; Haig A; Velenosi TJ; Urquhart BL
Biomed Pharmacother; 2023 Jul; 163():114787. PubMed ID: 37126930
[TBL] [Abstract][Full Text] [Related]
7. UPLC-ESI-IT-TOF-MS metabolomic study of the therapeutic effect of Xuefu Zhuyu decoction on rats with traumatic brain injury.
Fu C; Wu Q; Zhang Z; Xia Z; Ji H; Lu H; Wang Y
J Ethnopharmacol; 2019 Dec; 245():112149. PubMed ID: 31401321
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potential biomarkers in acute kidney injury by ultra-high-performance liquid chromatography-tandem quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS).
Chen C; Zhang P; Bao G; Fang Y; Chen W
Int Urol Nephrol; 2021 Dec; 53(12):2635-2643. PubMed ID: 33686532
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic profiling of urine-derived extracellular vesicles from rat model of drug-induced acute kidney injury.
Saito M; Horie S; Yasuhara H; Kashimura A; Sugiyama E; Saijo T; Mizuno H; Kitajima H; Todoroki K
Biochem Biophys Res Commun; 2021 Mar; 546():103-110. PubMed ID: 33581383
[TBL] [Abstract][Full Text] [Related]
10. Serum and urine metabolomics based on UPLC-Q-TOF/MS reveals the antipyretic mechanism of Reduning injection in a rat model.
Gao X; Huang C; Geng T; Chen X; Wang J; Liu J; Duan K; Cao L; Wang Z; Xiao W
J Ethnopharmacol; 2020 Mar; 250():112429. PubMed ID: 31812644
[TBL] [Abstract][Full Text] [Related]
11. Urine metabolomics insight into acute kidney injury point to oxidative stress disruptions in energy generation and H
Martin-Lorenzo M; Gonzalez-Calero L; Ramos-Barron A; Sanchez-Niño MD; Gomez-Alamillo C; García-Segura JM; Ortiz A; Arias M; Vivanco F; Alvarez-Llamas G
J Mol Med (Berl); 2017 Dec; 95(12):1399-1409. PubMed ID: 28975359
[TBL] [Abstract][Full Text] [Related]
12. Identification of Biomarkers of Sepsis-Associated Acute Kidney Injury in Pediatric Patients Based on UPLC-QTOF/MS.
Wang S; Xiao C; Liu C; Li J; Fang F; Lu X; Zhang C; Xu F
Inflammation; 2020 Apr; 43(2):629-640. PubMed ID: 31828589
[TBL] [Abstract][Full Text] [Related]
13. Study the therapeutic mechanism of Amomum compactum in gentamicin-induced acute kidney injury rat based on a back propagation neural network algorithm.
Wang X; Chen H; Chang C; Jiang M; Wang X; Xu L
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():81-88. PubMed ID: 27978472
[TBL] [Abstract][Full Text] [Related]
14. Urinary metabolic profiling of cisplatin nephrotoxicity and nephroprotective effects of Orthosiphon stamineus leaves elucidated by
Pariyani R; Ismail IS; Azam A; Khatib A; Abas F; Shaari K; Hamza H
J Pharm Biomed Anal; 2017 Feb; 135():20-30. PubMed ID: 27987392
[TBL] [Abstract][Full Text] [Related]
15. Urinary metabolomics of complete Freund's adjuvant-induced hyperalgesia in rats.
Liu Y; Chen H; Lu J; Jiang Y; Yang R; Gao S; Dong X; Chen W
Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 28058725
[TBL] [Abstract][Full Text] [Related]
16. Integrated metabolomic profiling for analysis of antilipidemic effects of
Yang XX; Wei JD; Mu JK; Liu X; Dong JC; Zeng LX; Gu W; Li JP; Yu J
World J Gastroenterol; 2018 Dec; 24(48):5505-5524. PubMed ID: 30622379
[TBL] [Abstract][Full Text] [Related]
17. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
18. Using intracellular metabolic profiling to identify novel biomarkers of cisplatin-induced acute kidney injury in NRK-52E cells.
Kim HR; Park JH; Lee SH; Kwack SJ; Lee J; Kim S; Yoon S; Kim KB; Lee BM; Kacew S; Kim HS
J Toxicol Environ Health A; 2022 Jan; 85(1):29-42. PubMed ID: 34445936
[TBL] [Abstract][Full Text] [Related]
19. Urine and plasma metabolomics study on potential hepatoxic biomarkers identification in rats induced by Gynura segetum.
Qiu S; Zhang H; Fei Q; Zhu F; Wang J; Jia X; Chen B
J Ethnopharmacol; 2018 Apr; 216():37-46. PubMed ID: 29353003
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics study of fasudil on cisplatin-induced kidney injury.
Xia D; Lai X; Wu K; Zhou P; Li L; Guo Z; Xu S
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31670380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
